Viking Therapeutics Inc Stock
€30.16
Your prediction
Viking Therapeutics Inc Stock
Pros and Cons of Viking Therapeutics Inc in the next few years
Pros
Cons
Performance of Viking Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 5.910% | 1.583% | 5.769% | 27.311% | -3.302% | 96.099% | 484.156% |
| Heron Therapeutics Inc. | -0.220% | 5.471% | -31.355% | -64.610% | -37.702% | -50.322% | -95.078% |
| Evolus Inc | -1.080% | 1.099% | 0.000% | -66.847% | -32.477% | -52.208% | -65.607% |
| Sangamo Therapeutics Inc. | 18.000% | -12.659% | -29.343% | -56.626% | -25.243% | -83.840% | -97.492% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Evaluating the financials of Viking, a company operating in the Biotechnology and Medical Research industry, reveals a noteworthy, albeit challenging financial landscape. The financial statements indicate struggles with revenue generation and profitability, evident from consistent net losses over the past three years. However, the potential for innovation and advancements in biotechnology keeps the door open for future growth, given the right strategic decisions.
The financial health of Viking underscores a crucial juncture: while the company possesses a significant market capitalization of approximately $6.42 billion, it has yet to convert this potential into revenue, as indicated by a total revenue figure of zero in the income statements. With negative earnings per share, mounting losses, and a dwindling cash flow, questions arise about its operational viability without a shift in its current trajectory. Nevertheless, the company holds substantial assets and cash reserves which could support R&D efforts crucial for breakthroughs in biotechnology.
Market Capitalization: Viking's substantial market capitalization suggests confidence from investors and signals a strong foundational value. This capitalization can provide leverage for further investments or strategic partnerships.
Comments
News
2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More
For stock investors, any beaten-down sector is worth combing through for bargains. These days, healthcare certainly qualifies; the S&P Composite 1500 Health Care index has ticked only marginally
Why Viking Therapeutics Stock Could Take Off Later This Year
The anti-obesity drug market is getting crowded. Many healthcare companies are working on their own GLP-1 drugs in an effort to take market share, which could amount to billions of dollars in
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
Every now and then, two investments land in front of you that look nothing alike but pose the same underlying questions: How much uncertainty are you willing to tolerate, and in what form? In that